폐경 후 여성에서 아디포카인과 비만 및 대사 합병증

키워드

참고문헌 (74)

1. Flegal KM, "Prevalence and trends in obesity among US adults, 1999-2000", JAMA, 28, pp.1723~1727 (2002)
2. 보건복지부, "국민건강영양조사", 37~43 (2005)
3. Bray GA, "Medical consequences of obesity", J Clin Endocrinol Metab, 89, pp.2583~2589 (2004)
4. Parati G, "Sleep apnea: epidermiology, pathophysiology, and relation to cardiovascular risk", Am J Physiol Regul Integr Comp Physiol, 293, pp.R1671~R1683 (2007)
5. Kuczmarski RJ, "Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991", JAMA, 272, pp.205~211 (1994)
6. Pasquali R, "Body weight, fat distribution and the menopausal status in women. The VMH Collaborative Group", Int J Obes Related Metab Disord, 18, pp.614~621 (1994)
7. Sowers MF, "Changes in body composition in women in women over six years at midlife: ovarian and chronological aging", J Clin Endocrinol Metab, 92, pp.895~901 (2007)
8. Lindheim SR, "Comparison of estimates of insulin sensitivity in pre- and postmenopausal women using the insulin tolerance test and the frequently sampled intravenous glucose tolerance test", J Soc Gynecol Investig, 1, pp.150~154 (1994)
9. Carr MC, "The emergence of the metabolic syndrome with menopause", J Clin Endocrinol Metab, 88, pp.2404~2411 (2003)
10. Gohlke-Bärwolf C, "Coronary artery disease - is menopause a risk factor?", Basic Res Cardiol, 95(1), pp.I77~I83 (2000)
11. Moschos S, "Leptin and reproduction: a review", Fertil Steril, 77, pp.433~444 (2002)
12. Hotamisligil GS, "Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance", Science, 259, pp.87~91 (1993)
13. Kern PA, "The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss and relationship to lipoprotein lipase", J Clin Invest, 95, pp.2111~2119 (1995)
14. Kumada M, "Association of hypoadiponectinemia woth coronary artery disease in men", Arterioscler Thromb Vasc Biol, 23, pp.87~89 (2003)
15. Wellen KE, "Obesity-induced inflammatory changes in adipose tissue", J Clin Invest, 112, pp.1785~1788 (2003)
16. Xu H, "Chronic inflammation in fat plays a crucial role in the development of obesityrelated insulin resistance", J Clin Invest, 112, pp.1821~1830 (2003)
17. Sierra-Honigmann MR, "Biological action of leptin as an angiogenic factor", Science, 281, pp.1683~1686 (1998)
18. Maeda N, "Diet-induced insulin resistance in mice lacking adiponectin", ACRP30, 2002, pp.8, 731~737
19. Arkan MC, "IKK-β links inflammation to obesity-induced insulin resistance", Nat Med, 11, pp.191~198 (2005)
20. Di Gregorio GB, "Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone", Diabetes, 54, pp.2305~2313 (2005)
21. Cinti S, "Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans", J Lipid Res, 46, pp.2347~2355 (2005)
22. Plomgaard P, "Tumor necrosis factor-α induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation", Diabetes, 54, pp.2939~2945 (2005)
23. Ofei F, "Effects of an engineered human anti-TNF- α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM", Diabetes, 45, pp.881~885 (1996)
24. Emanuelli B, "SOCS-3 is an insulin-induced negative regulator of insulin signaling", J Biol Chem, 275, pp.15985~15991 (2000)
25. Ruderman NB, "Interleukin-6 regulation of AMP-activated protein kinase. Potential role in the systemic response to exercise and prevention of the metabolic syndrome", Diabetes, 55(2), pp.S48~S54 (2006)
26. Wellen KE, "Obesity-induced inflammatory changes in adipose tissue", J Clin Invest, 112, pp.1785~1788 (2003)
27. Kiefer FW, "Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations", Endocrinology, 149, pp.1350~1357 (2008)
28. Rosen ED, "PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth", J Biol Chem, 276, pp.37731~37734 (2001)
29. Wilson TM, "The PPARs: from orphan receptors to drug discovery", J Med Chem, 43, pp.527~550 (2000)
30. Auboeuf D, "Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferators-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients", Diabetes, 46, pp.1319~1327 (1997)
31. Singh Ahuja H, "Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents", Mol Pharmacol, 59, pp.765~773 (2001)
32. Alberti KG, "Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation", Diabet Med, 15, pp.539~553 (1998)
33. Wu Z, "PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C", EBPalpha during the conversion of 3T3 fibroblasts into adipocytes, 1998, pp.101, 22~32
34. Hardie DG, "The AMP-activated protein kinase. Fuel gauge of the mammalian cell?", Eur J Biochem, 246, pp.259~273 (1997)
35. Windler WW, "AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes", Am J Physiol, 277, pp.E1~E10 (1999)
36. Carling D, "The AMP-activated protein kinase cascade - a unifying system for energy control", Trends Biochem Sci, 29, pp.18~24 (2004)
37. Henin N, "Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase", FASEB J, 9, pp.541~546 (1995)
38. McGarry JD, "Glucose-fatty acid interactions in health and disease", Am J Clin Nutr, 67(3), pp.500S~504S (1998)
39. Sullivan JE, "Inhibition of lypolysis and lipogenesis in isolated rat hepatocytes with AICAR, a cell permeable activator of AMP-activated protein kinase", FEBS Lett, 353, pp.33~36 (1994)
40. Hayashi T, "Exercise regulation of glucose transport in skeletal muscle", Am J Physiol, 273(6), pp.E1039~E1051 (1997)
41. Salt IP, "AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic β cells, and may regulate insulin release", Bichem J, 335, pp.533~539 (1998)
42. Zhang Y, "Positional cloning of the mouse obese gene and its human homologue", Nature, 372, pp.425~432 (1994)
43. Cone RD, "The arcuate nucleus conduit diverse signals relevant to energy homeostasis", Int J Obes Relat Metab Disord, 25(5), pp.S63~S67 (2001)
44. Mercer JG, "Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization", FEBS Lett, 387, pp.113~116 (1996)
45. Buttner C, "Critical role of STAT3 in leptin's metabolic action", Cell Metab, 4, pp.49~60 (2006)
46. Buettner C, "Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms", Nat Med, 14, pp.667~675 (2008)
47. Load GM, "Leptin modulates the T-cell immune reponse and reveres starvation-induced immunosuppression", Nature, 394, pp.897~901 (1998)
48. Mantzoros CS, "Leptin concentration in relation to body mass index and the tumor necrosis factor-alpha system in humans", J Clin Endocrinol Metab, 82, pp.3408~3413 (1997)
49. Unger RH, "Lipid overload and overflow: metabolic trauma and the metabolic syndrome", Trends Endocrinol Metab, 14, pp.398~403 (2003)
50. Franks PW, "Leptin predicts worsening of the features of the metabolic syndrome independently of obesity", Obes Res, 13, pp.1476~1484 (2005)
51. Scherer PE, "A novel serum protein similar to C1q, produced exclusively in adipocytes", J Biol Chem, 270, pp.26746~26749 (1995)
52. Weyer C, "Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia", J Clin Endocrinol Metab, 86, pp.1930~1935 (2001)
53. Kadowaki T, "Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome", J Clin Invest, 116, pp.1784~1792 (2006)
54. Kadowaki T, "Adiponectin and adiponectin receptors", Endocr Rev, 26, pp.439~451 (2005)
55. Rasouli N, "Pioglitazone improves insulin sensitivity through reduction in muscle lipid and redistribution of lipid into adipose tissue", Am J Phusiol Endocrinol Metab, 288, pp.E930~E934 (2005)
56. Matsuzawa Y, "Adiponectin and metabolbic syndrome", Arterioscler Thromb Vasc Biol, 24, pp.29~33 (2004)
57. Ouchi N, "Adiponectin, an adipocytederived plasma protein, inhibits endothelial NF-kB shinaling throuch a cAMP-dependent pathway", Circulation, 102, pp.1296~1301 (2000)
58. Ouchi N, "Adipocutederived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages", Circulation, 103, pp.1057~1063 (2001)
59. Steppan CM, "The hormone resistin links obesity to diabetes", Nature, 409, pp.307~312 (2001)
60. Vozarova de Courten B, "High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians", Diabetes, 53, pp.1279~1284 (2004)
61. Yang Q, "Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes", Nature, 436, pp.356~362 (2005)
62. Graham TE, "Retinolbinding protein 4 and insulin resistance in lean, obese, and diabetic subjects", N Engl J Med, 354, pp.2552~2563 (2006)
63. von Eynatten M, "Retinol-binding protein 4 is associated with component of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease", Diabetologia, 50, pp.1930~1937 (2007)
64. Fukuhara A, "Visfatin: a protein secreted by visceral fat that mimics the effects of insulin", Science, 307, pp.426~430 (2005)
65. Berndt J, "Plasma visfatin concentrations and fat depot-specific mRNA expression in humans", Diabetes, 54, pp.2911~2916 (2005)
66. Varma V, "Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipid and inflammation", J Clin Endocrinol Metab, 92, pp.666~672 (2007)
67. Tsai EM, "Leptin affects pregnancy outcome of in vitro fertilization and steroidogenesis of human granulose cells", J Assist Reprd Genet, 19, pp.169~176 (2002)
68. Agarwal SK, "Leptin antagonizes the insulin-like growth factor-1 augmentation of steroidogenesis in granulose and theca cells of the human ovary", J Clin Endocrinol Metab, 84, pp.1072~1076 (1999)
69. Bednarek-Tupikowska G, "Serum leptin concentrations in preand postmenopausal women on sex hormone therapy", Gynecol Endocrinol, 22, pp.207~212 (2006)
70. Sowers MR, "Change in adipocytokines and ghrelin with menopause", Maturitas, 59, pp.149~157 (2008)
71. Chu MC, "Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin", Am J Obstet Gynecol, 194, pp.100~104 (2006)
72. Di Carlo C, "Serum leptin levels in postmenopausal women: effect of transdermal hormone replacement therapy", Menopause, 7, pp.36~41 (2000)
73. Lin KC, "Increase of leptin levels following exogenous administration of estrogen in women with normal menstruation", Kaohsiung J Med Sci, 16, pp.13~19 (2000)
74. Bednarek-Tupikowska G, "Serum leptin concentrations in preand postmenopausal women on sex hormone therapy", Gynecol Endocrinol, 22, pp.207~212 (2006)

관련 논문AI추천